3 Myelofibrosis Clinical Trials in Columbus, OH (2026)

Q: How do I join a clinical trial in Columbus?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbus research site will contact you.

Recruiting Myelofibrosis Studies in Columbus

NCT06343805Recruiting

A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)

AJX-101 is a first-in-human (FIH), phase 1, non-randomized, multi-center, open-label clinical trial designed to investigate the safety, tolerability, pharmacokinetics (PK), clinical activity and chang...

Columbus, OHPHASE1256 participantsAjax Therapeutics, Inc.

View Study Details

NCT07774455Recruiting

Pacritinib Effectiveness in Real-world Settings

This study aims to evaluate real-world treatment patterns and effectiveness of pacritinib, including hematologic and clinical outcomes, and survival through a site-based retrospective chart review of ...

Columbus, OH60 participantsSwedish Orphan Biovitrum

View Study Details

NCT05835466Recruiting

Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)

This is an open label, phase II study to assess the efficacy, safety, and tolerability of Reparixin in patients with DIPSS intermediate-2, or high-risk primary myelofibrosis (PMF), post essential thro...

Columbus, OHPHASE210 participantsIcahn School of Medicine at Mount Sinai

View Study Details

About Myelofibrosis Clinical Trials in Columbus

Myelofibrosis is a serious bone marrow disorder that disrupts normal blood cell production, leading to extensive scarring in the bone marrow. It can cause severe anemia, weakness, and an enlarged spleen. Treatment includes JAK inhibitors, blood transfusions, and stem cell transplant.

There are currently 3 myelofibrosis clinical trials recruiting participants in Columbus, OH. These studies are seeking a combined 326 participants. Research is being sponsored by Ajax Therapeutics, Inc., Swedish Orphan Biovitrum, Icahn School of Medicine at Mount Sinai. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myelofibrosis Clinical Trials in Columbus — FAQ

Are there myelofibrosis clinical trials in Columbus?

Yes, there are 3 myelofibrosis clinical trials currently recruiting in Columbus, OH. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Columbus?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbus research site will contact you about next steps.

Are clinical trials in Columbus free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbus studies also compensate for your time and travel.

What myelofibrosis treatments are being tested?

The 3 active trials in Columbus are testing new therapies including novel drugs, biologics, and treatment approaches for myelofibrosis.

Data updated October 16, 2026 from ClinicalTrials.gov